File:Androgen backdoor pathway from 17-OHP to DHT.svg
Jump to navigation
Jump to search
Size of this PNG preview of this SVG file: 310 × 488 pixels. Other resolutions: 152 × 240 pixels | 305 × 480 pixels | 488 × 768 pixels | 650 × 1,024 pixels | 1,301 × 2,048 pixels.
Original file (SVG file, nominally 310 × 488 pixels, file size: 60 KB)
File history
Click on a date/time to view the file as it appeared at that time.
Date/Time | Thumbnail | Dimensions | User | Comment | |
---|---|---|---|---|---|
current | 23:05, 14 June 2022 | 310 × 488 (60 KB) | Maxim Masiutin | Need to use Capitalized names | |
22:57, 14 June 2022 | 310 × 488 (60 KB) | Maxim Masiutin | Made consistent steroid names and added abbreviations | ||
11:45, 4 November 2020 | 256 × 440 (47 KB) | Maxim Masiutin | Previous file had improper structure rendering | ||
02:49, 4 November 2020 | 310 × 488 (45 KB) | Maxim Masiutin | Added chemical structures | ||
19:29, 22 October 2020 | 376 × 432 (4 KB) | Maxim Masiutin | The text did not always fit the boxes | ||
19:25, 22 October 2020 | 277 × 432 (6 KB) | Maxim Masiutin | {{subst:Upload marker added by en.wp UW}} {{Information |Description = {{en|he androgen backdoor pathway can be outlined as 17α-hydroxyprogesterone (17-OHP) → 5α-pregnan-17α-ol-3,20-dione (17‐OH-DHP) → 5α-pregnane-3α,17α-diol-20-one (5α-pdiol) → 5α-androstan-3α-ol-17-one (androsterone) → 5α-androstane-3α,17β-diol (3α-diol) → 5α-dihydrotestosterone (DHT)}} |Source = Using the Visio editor |Date = 2020-10-22 |Author = Maxim Masiutin }} |
File usage
No pages embed this file. However pages may still include links to this file.